Clinical trial
Omics Gaucher Study: Multiomic Approach To Describe The Gaucher Disease Treatment Dynamics In Comparison To Untreated Healthy Volunteers
NCT05526664 is registered in ClinicalTrials.gov with CENTOGENE GmbH Rostock as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Omics Gaucher Study: Multiomic Approach To Describe The Gaucher Disease Treatment Dynamics In Comparison To Untreated Healthy Volunteers
- Lead sponsor
- CENTOGENE GmbH Rostock
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- October 6, 2022
- Completion date
- December 31, 2025
- Enrollment
- 25 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.